Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors

BACKGROUND: Increased body mass index (BMI) has been associated with improved response to immune checkpoint inhibitors (ICIs) in multiple cancer types. We evaluated associations between BMI, ICI dosing strategy, and clinical outcomes. METHODS: We abstracted clinical data on patients with cancer trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Murtaza, von Itzstein, Mitchell S, Sheffield, Thomas, Khan, Shaheen, Fattah, Farjana, Park, Jason Y, Popat, Vinita, Saltarski, Jessica M, Gloria-McCutchen, Yvonne, Hsiehchen, David, Ostmeyer, Jared, Khan, Saad A, Sultana, Nazima, Xie, Yang, Li, Quan-Zhen, Wakeland, Edward K, Gerber, David E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237749/
https://www.ncbi.nlm.nih.gov/pubmed/34127546
http://dx.doi.org/10.1136/jitc-2021-002349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237749/
https://www.ncbi.nlm.nih.gov/pubmed/34127546
http://dx.doi.org/10.1136/jitc-2021-002349

Ejemplares similares